Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Liver Diseases

Free Subscription 18.05.2026 1 Am J Pathol 4 Biochem Biophys Res Commun 1 BMC Cancer 4 BMC Gastroenterol 1 Endoscopy 1 Eur Radiol 2 Gastroenterology 5 Gut 1 Hepatology 3 J Gastroenterol 6 J Hepatol 1 J Pediatr Surg 2 Oncogene 3 PLoS One 1 Radiology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Pathol

1. BANO S, Copeland MA, Liu JJ, Orr A, et al
   Hepatocyte-specific PPARgamma Deletion Uncovers Role of an Antagonistic PPARgamma-HNF4alpha Transcriptional Axis in MASLD Progression.
   Am J Pathol. 2026 May 11:S0002-9440(26)00137.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

2. KARUNAKARA SH, Santhekadur PK
   MicroRNA clusters as regulators in progressive fatty liver disease Spectrum: from mechanistic insights to therapeutic opportunities.
   Biochem Biophys Res Commun. 2026;819:153846.
   PubMed         Abstract available
   
   
3. ZHOU X, Chen Y, Li J, Zhang Y, et al
   Tumor cell-derived IL-23 promotes hepatocellular carcinoma progression via an autocrine IL-23/EGFR/AKT signaling axis.
   Biochem Biophys Res Commun. 2026;822:153893.
   PubMed         Abstract available
   
   
4. BAI L, Wang Y, Li G, Song Y, et al
   Corrigendum to "YEATS2/TAK1 axis mediates TGF-beta1 driven adaptive resistance to sorafenib in hepatocellular carcinoma" [Biochem. Biophys. Res. Commun. 817 (2026) 153693].
   Biochem Biophys Res Commun. 2026;820:153863.
   PubMed        
   
   
5. ZHANG J, Yuan J, Cheng W, Tang H, et al
   Inhibition of FKBP10 attenuates hepatic stellate cell activation and liver fibrosis via RAS signaling.
   Biochem Biophys Res Commun. 2026;821:153835.
   PubMed         Abstract available
   
   

   
   BMC Cancer

6. XIA X, Xu H, Lin G, Chen L, et al
   Single-cell and machine learning reveal ROS-associated heterogeneity in hepatocellular carcinoma for precision medicine.
   BMC Cancer. 2026 May 14. doi: 10.1186/s12885-026-16099.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

7. MAHMOUD MS, Mshaly MS, Abdel-Reheim HN, Shawki MM, et al
   Electronic nose versus gas chromatography - mass spectrometry for diagnostic discrimination of advanced hepatocellular carcinoma by volatolomic analysis.
   BMC Gastroenterol. 2026;26:284.
   PubMed         Abstract available
   
   
8. ABDULLA MM, Salama OE, El-Husseiny G, Ziady HH, et al
   Trends in gastrointestinal cancers at a major tertiary hospital in Alexandria, Egypt: a 10-year retrospective study (2010-2019).
   BMC Gastroenterol. 2026;26:282.
   PubMed         Abstract available
   
   
9. ANANCHUENSOOK P, Treeprasertsuk S, Komolmit P, Thanapirom K, et al
   Liver stiffness by non-invasive tests predicts hepatocellular carcinoma and liver-related complications following viral eradication with direct-acting antivirals in chronic hepatitis C: a retrospective cohort study.
   BMC Gastroenterol. 2026 May 14. doi: 10.1186/s12876-026-04920.
   PubMed         Abstract available
   
   
10. LIAN J, Cui H, Xu B, Ye Q, et al
    A prospective cohort-based prediction model incorporating acute gastrointestinal injury for 28-day and 90-day outcomes in acute decompensation of cirrhosis.
    BMC Gastroenterol. 2026 May 14. doi: 10.1186/s12876-026-04922.
    PubMed         Abstract available
    
    

    
    Endoscopy

11. HIRATA Y, Akahide C, Hatada M, Nakamura S, et al
    Endoscopic removal using perioral cholangioscopy for biliary migration of vascular coil placed to treat biliary tract bleeding caused by ruptured right hepatic artery aneurysm.
    Endoscopy. 2026;58.
    PubMed        
    
    

    
    Eur Radiol

12. CHO SW, Kim Y, Park J, Park JH, et al
    Bone marrow R2* correlates with liver iron load and is associated with decreased survival in patients with cirrhosis without liver iron overload.
    Eur Radiol. 2026 May 11. doi: 10.1007/s00330-026-12614.
    PubMed         Abstract available
    
    

    
    Gastroenterology

13. PARIKH ND, Singal AG
    Not So Fast, My Friend: Biomarkers May Play an Important Role in Hepatocellular Carcinoma Surveillance.
    Gastroenterology. 2026 Apr 29:S0016-5085(26)06769.
    PubMed        
    
    
14. NI B, Wang H
    Toward Precision Hepatocellular Carcinoma Surveillance: Standardizing Ultrasound Visualization and Optimizing Biomarker Integration.
    Gastroenterology. 2026 Apr 29:S0016-5085(26)06768.
    PubMed        
    
    

    
    Gut

15. LI Q, Zhou S, Zhang L, Yu K, et al
    Landscape screening identifies the lactate-modifying enzyme AARS2 as a master regulator and therapeutic target in hepatocellular carcinoma.
    Gut. 2026 May 11:gutjnl-2025-337330. doi: 10.1136/gutjnl-2025-337330.
    PubMed         Abstract available
    
    
16. CAO M, Wei F, Georges D, Alberts CJ, et al
    Hepatocellular carcinoma attributable to hepatitis B, hepatitis C and other risk factors at global, regional and national levels: an updated systematic review and meta-analysis.
    Gut. 2026 May 14:gutjnl-2025-337838. doi: 10.1136/gutjnl-2025-337838.
    PubMed         Abstract available
    
    
17. RATZIU V, Surabattula R, Bugianesi E, Schattenberg JM, et al
    Thrombospondin-2 is a performant biomarker of at-risk MASH and advanced MASH fibrosis in a large multicentre European cohort.
    Gut. 2026;75:1226-1236.
    PubMed         Abstract available
    
    
18. SUO Y, Thimme R, Bengsch B
    Spatial single-cell omics: new insights into liver diseases.
    Gut. 2026;75:1248-1263.
    PubMed         Abstract available
    
    
19. FANG J, Zhong S, Wang T, He K, et al
    Immune-related adverse events are a potent predictor of post-transplant rejection in HCC: a multicentre retrospective cohort study.
    Gut. 2026;75:1201-1210.
    PubMed         Abstract available
    
    

    
    Hepatology

20. GUPTA P, Singh S, Gulati A, Mudgil P, et al
    Non-contrast abbreviated MRI demonstrates superior diagnostic accuracy compared to ultrasound for hepatocellular carcinoma detection: Interim results from a prospective surveillance trial.
    Hepatology. 2026 May 11. doi: 10.1097/HEP.0000000000001788.
    PubMed         Abstract available
    
    

    
    J Gastroenterol

21. YOSHIDA Y, Kumada T, Hirooka M, Ogawa S, et al
    Steatosis index: a novel multiparametric ultrasound approach for accurate liver steatosis quantification and grading.
    J Gastroenterol. 2026;61:592-602.
    PubMed         Abstract available
    
    
22. WU J, Miao H, Yuan W, Yao Y, et al
    Single-cell transcriptomics unveils the immunologic landscape of anti-PD-1-associated indirect drug-induced liver injury.
    J Gastroenterol. 2026;61:603-624.
    PubMed         Abstract available
    
    
23. MIWA T, Hsu CL, Shimizu M, Bloom PP, et al
    Covert hepatic encephalopathy as a multi-organ syndrome: the gut-liver-muscle-brain axis, diagnosis, treatment, and multidisciplinary care.
    J Gastroenterol. 2026 May 8. doi: 10.1007/s00535-026-02425.
    PubMed         Abstract available
    
    

    
    J Hepatol

24. TAGGART DJ, Mahajan S, Gallant MA, Pinkoviezky I, et al
    A Multi-Analyte cfDNA-based Blood Test for Early Detection of Hepatocellular Carcinoma.
    J Hepatol. 2026 May 6:S0168-8278(26)00215-1. doi: 10.1016/j.jhep.2026.
    PubMed         Abstract available
    
    
25. KUENTZEL KB, Trammell SAJ, Hassing AS, Bradic I, et al
    Arachidonoyl-taurine is elevated in human MASLD and protects against hepatic steatosis and inflammation in preclinical models.
    J Hepatol. 2026 May 9:S0168-8278(26)00271-0. doi: 10.1016/j.jhep.2026.
    PubMed         Abstract available
    
    
26. XIONG HL, Zhao Q, Liu SQ, Chen LL, et al
    Rifaximin ameliorates cirrhotic portal hypertension through suppression of microbiome-derived deoxycholic acid.
    J Hepatol. 2026 May 11:S0168-8278(26)00270-9. doi: 10.1016/j.jhep.2026.
    PubMed         Abstract available
    
    
27. SILVESTER HOFER B, Tonon M, Reiberger T
    Reply to: "Early Abstinence, Socioeconomic Barriers, and Survival in Decompensated Alcohol-Related Cirrhosis: A Real-World Cohort from China".
    J Hepatol. 2026 May 12:S0168-8278(26)00278-3. doi: 10.1016/j.jhep.2026.
    PubMed        
    
    
28. JEPSEN P, Watson H, Vilstrup H
    A call for sharing individual patient data from trials in hepatology.
    J Hepatol. 2026 May 13:S0168-8278(26)00277-1. doi: 10.1016/j.jhep.2026.
    PubMed         Abstract available
    
    
29. FELLI E, Nulan Y, Ortega-Ribera M, Fernandez-Iglesias A, et al
    The role of liver sinusoidal endothelial cells in liver diseases: Key players in health and pathology.
    J Hepatol. 2026;84:655-672.
    PubMed         Abstract available
    
    

    
    J Pediatr Surg

30. HICKNER BT, Espinoza AF, Masand PM, Lopez-Terrada DH, et al
    Oncologic Outcomes of Parenchyma-Sparing Resection for Hepatoblastoma.
    J Pediatr Surg. 2026 May 6:163195. doi: 10.1016/j.jpedsurg.2026.163195.
    PubMed         Abstract available
    
    

    
    Oncogene

31. DAI Q, Lou L, Zhu X, Zhao H, et al
    TIAL1 regulates the Hippo pathway through an RNA-binding-independent mechanism.
    Oncogene. 2026;45:1941-1951.
    PubMed         Abstract available
    
    
32. KITISIN K, Ganesan N, Tang Y, Jogunoori W, et al
    Editorial Expression of Concern: Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation.
    Oncogene. 2026 May 11. doi: 10.1038/s41388-026-03821.
    PubMed        
    
    

    
    PLoS One

33. XU X, Tang L, Piao X, Zhan S, et al
    Economic evaluation of finotonlimab plus bevacizumab as first-line therapy for advanced hepatocellular carcinoma.
    PLoS One. 2026;21:e0349044.
    PubMed         Abstract available
    
    
34. BLANCO-ECHEVARRIA A, Costa Segovia R, Guijarro Herraiz C, Garcia Izquierdo B, et al
    Role of activity and fibrosis in the MASLD atherogenic momentum through advanced lipidomics.
    PLoS One. 2026;21:e0343134.
    PubMed         Abstract available
    
    
35. CHAROENCHUE P, Rajchakom K, Amantakul A, Pojchamarnwiputh S, et al
    Diagnostic performance of abbreviated non-contrast liver MRI for detecting synchronous colorectal liver metastases.
    PLoS One. 2026;21:e0348972.
    PubMed         Abstract available
    
    

    
    Radiology

36. WANG TC, Wei N, Bao Y, Li JX, et al
    CT Radiomics-based Machine Learning to Identify Intratumoral Fibrosis and Underlying Angiogenesis in Hepatocellular Carcinoma.
    Radiology. 2026;319:e250736.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum